Cite

HARVARD Citation

    Corre, S. et al. (2018). Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma. Nature communications. 9 (1), pp. 1-13. [Online]. 
  
Back to record